Does Afatinib Plus Bevacizumab Combination Therapy Induce Positive Conversion of T790M in Previously-Negative Patients?
Oncotarget - United States
doi 10.18632/oncotarget.26192
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 24, 2018
Authors
Publisher
Impact Journals, LLC